(Q33949743)

English

Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

30 July 2017

anti-retroviral agent

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

author name string

Rafael de La Rosa

1

1 reference

Europe PubMed Central

30 July 2017

Juan A Pineda

2

1 reference

Europe PubMed Central

30 July 2017

Juan Delgado

3

1 reference

Europe PubMed Central

30 July 2017

Juan Macías

4

1 reference

Europe PubMed Central

30 July 2017

Francisco Morillas

5

1 reference

Europe PubMed Central

30 July 2017

José A Mira

6

1 reference

Europe PubMed Central

30 July 2017

Armando Sánchez-Quijano

7

1 reference

Europe PubMed Central

30 July 2017

Manuel Leal

8

1 reference

Europe PubMed Central

30 July 2017

Eduardo Lissen

9

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

30 July 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

30 July 2017

40

1 reference

Europe PubMed Central

30 July 2017

3

1 reference

Europe PubMed Central

30 July 2017

762-767

1 reference

Europe PubMed Central

30 July 2017

Recurrent cutaneous leishmaniasis: a role for persistent parasites?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Leishmania-HIV interaction: immunopathogenic mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Kala-azar comes to New York

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Is leishmaniasis ever cured?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

5 July 2018

Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

29 October 2018

Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=120223

29 October 2018

Delayed hypersensitivity skin testing and anergy in a population of gay men

1 reference

https://pubmed.ncbi.nlm.nih.gov/11880390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/11880390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11880390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi

1 reference

https://pubmed.ncbi.nlm.nih.gov/11880390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Impact of medical approach on the presentation form of AIDS defined by clinical episodes]

1 reference

https://pubmed.ncbi.nlm.nih.gov/11880390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11880390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11880390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential factors affecting adherence with HIV therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11880390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.40.3.762-767.2002

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33949743&oldid=1979178025"